CapsoVision $CV continues to show itself to be an exciting MedTech company with ambitions - and the current share price of USD 7.19 reflects the growing interest. 📈
🔎 What's happening right now
- In Q3 2025, CapsoVision reported revenue of USD 3.5 million - a growth of +19% YoY. And the number of new customers increased by 31% compared to the same quarter last year.
- The use of the existing capsule endoscopy technology CapsoCam Plus is working: By the end of Q3, it had already been used on over 151,000 patients.
- At the same time, CapsoVision is pushing ahead with its product pipeline: the company recently submitted an application to the U.S. Food and Drug Administration (FDA) for a capsule for the early detection of pancreatic cancer - with the aim of a "Breakthrough Device Designation".
Who has the share on their watchlist or is also invested?
#medtech
#smallcap
#capsovision
#cv
#capsuleendoscopy
#healthtech
#innovation
#investing
#biotech
#growthpotential
#riskandreward
#aktie
#aktien
#nasdaq
#nyse
#crypto
#börse
#dax
